Evidence map›Paper›PMID 31171931›Full record

ArticleSource code for biology and medicine2019

MZPAQ: a FASTQ data compression tool.

Achraf El Allali, Mariam Arshad

Open access · hybridAbstract read
In one paragraph

Article in Source code for biology and medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Achraf El AllaliDepartment of Computer Science, College of computer and Information Sciences, King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0002-4561-2161
Mariam ArshadDepartment of Computer Science, College of computer and Information Sciences, King Saud University, Riyadh, Saudi Arabia.
King Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDue to the technological progress in Next Generation Sequencing (NGS), the amount of genomic data that is produced daily has seen a tremendous increase. This increase has shifted the bottleneck of genomic projects from sequencing to computation and specifically storing, managing and analyzing the large amount of NGS data. Compression tools can reduce the physical storage used to save large amount of genomic data as well as the bandwidth used to transfer this data. Recently, DNA sequence compression has gained much attention among researchers.

resultsIn this paper, we study different techniques and algorithms used to compress genomic data. Most of these techniques take advantage of some properties that are unique to DNA sequences in order to improve the compression rate, and usually perform better than general-purpose compressors. By exploring the performance of available algorithms, we produce a powerful compression tool for NGS data called MZPAQ. Results show that MZPAQ outperforms state-of-the-art tools on all benchmark datasets obtained from a recent survey in terms of compression ratio. MZPAQ offers the best compression ratios regardless of the sequencing platform or the size of the data.

conclusionsCurrently, MZPAQ's strength is its higher compression ratio as well as its compatibility with all major sequencing platforms. MZPAQ is more suitable when the size of compressed data is crucial, such as long-term storage and data transfer. More efforts will be made in the future to target other aspects such as compression speed and memory utilization.

Indexed as

DNA compressionFASTA filesFASTQ filesNext generation sequences

Identifiers

PMID31171931
PMCPMC6547476
OpenAlexW2948131040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.